Search Results
From the helm: Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer
Cyclopharm (ASX:CYC) announces expansion of PET diagnostics business opportunities
Cyclopharm (ASX:CYC) talks lung disease screening
CycloPharm presentation at Meet the CEO 3 March 2022
Investor Webinar 5 April 2023: Cyclopharm (ASX:CYC), using a Stop Loss and why we're looking at ...
On Liberty Ep.4 | James McBrayer | Australian pharmaceutical CEO on challenges during Covid-19
Cyclopharm 2023 Annual General Meeting May 16th
Technegas™ Functional Lung Imaging
Morning Bell 8 February
Tribute to our Dad, Roland James Amir
The Gospel Journal - Online Lectureship Series - August 9, 2022 - Matthew McBrayer - A Minute In Hel
Weekly Wrap February 5
